Developer docs
API playgroundTry for free, no card

Search company profiles

FindAir

Full company profile

uuid0002oth

Namestring
FindAir
Legal namestring
Findair Sp. z o. o.
Websiteurl
findair.eu
Company typeenum
Private
Founded yearint
2016
Descriptiontext

FindAir (FindAir Sp. z o.o.) is a Kraków, Poland-based med-tech company founded in 2016 that develops smart inhaler technology and software for asthma and COPD management. Its product portfolio comprises three device families: FindAir ONE add-on sensors compatible with seven inhaler types (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler); Smarthaler Trainer (Home and Station) devices for AI-powered inhalation technique training; and Smarthaler Drug Delivery for pharmaceutical OEM and modular integration. The software stack includes mobile apps (FindAir Asthma Diary, FindAir Research App, FindAir Smarthaler App), web platforms (Doctor's Platform, Research Platform), an API and SDK for third-party integration, and AsthmaAI, a branded AI module for asthma and COPD exacerbation prediction. The company operates under ISO 13485, CE, FCC, and GDPR certifications.

FindAir generates revenue through five streams: hardware sales of FindAir ONE add-ons and Smarthaler devices via its own e-commerce store; subscription/recurring revenue from software platforms and apps; licensing and OEM/white-label partnerships with pharmaceutical companies for custom smart inhaler development; SDK and API integration services for healthcare platforms, EHRs, and research systems; and channel sales through medical device distributors. Pricing is quote-based with multi-year contracts and no public price list. Go-to-market is sales-led, combining direct enterprise outreach, industry events (TechCrunch Disrupt, Arab Health), content marketing, and distributor partnerships. Customer segments include remote patient monitoring services, pharmaceutical and drug delivery companies, health clinics and medical institutions, research and clinical trial sponsors, and medical device distributors, with named relationships including AstraZeneca, Aptar, University Health Network, Radboud UMC, UF Health, Asthma UK, University of Leicester, and RespoGene. The company operates from Poland with commercial activity across Germany, France, Portugal, and a stated US expansion initiative backed by a $1.9M seed round closed in June 2023.

Short descriptiontext

FindAir is a Kraków-based med-tech company developing smart inhaler sensors, AI-powered inhalation training devices, and connected drug delivery technology for asthma and COPD patients, serving healthcare providers, pharmaceutical companies, clinical researchers, and medical device distributors across Europe and the US.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCracow, Poland
HQ citystring
Cracow
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smart inhaler technology, respiratory care devices, medication adherence monitoring, connected drug delivery, asthma COPD management
Industry2 codes
PRIMARYHLAHAIAM
Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Smart Inhaler Technology and Respiratory Care Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Smart Inhaler Hardware Sales
TypeHardware Sales
Description

Sale of FindAir ONE add-on sensors that attach to existing inhalers for medication monitoring. Devices are sold directly through the company store and via distributors.

findair.eu
2Smarthaler Device Sales
TypeHardware Sales
Description

Sale of Smarthaler Trainer devices (Home and Station versions) for inhalation technique training, both for personal/home use and professional clinical settings.

findair.eu
3Software Platform & Apps
TypeSubscription Recurring
Description

Mobile apps (FindAir Asthma Diary, FindAir Research App, FindAir Smarthaler App) and web platforms (Doctor's Web Platform, Research Web Platform) with associated data monitoring and analytics capabilities.

findair.eu
4Pharma OEM/White-label Partnerships
TypeLicensing Royalties
Description

Custom smart inhaler development partnerships with pharmaceutical companies to integrate Smarthaler technology into their drug delivery devices, including complete design history files and regulatory support.

findair.eu
5SDK & API Integration Services
TypeManaged Services
Description

Developer integration services enabling healthcare platforms, EHRs, and research systems to connect with FindAir devices through APIs and SDKs.

findair.eu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based pricing for all products
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available; contact sales for quotes on FindAir ONE add-ons, Smarthaler devices, and software platforms.

findair.eu
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1FindAir ONE
Description

Smart inhaler add-on sensors that attach to existing inhalers for medication intake monitoring and adherence tracking

findair.eu
+5 more records
Core offering1 text field

FindAir designs and manufactures smart inhaler add-on sensors (FindAir ONE) that attach to existing inhaler types (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) to automatically log medication usage. The company also produces the Smarthaler Trainer (Home and Station variants) for AI-powered inhalation technique training, and offers Smarthaler Drug Delivery technology for pharmaceutical partners to integrate connected monitoring into their inhaler devices. These hardware products are complemented by mobile apps, web platforms for clinicians and researchers, and the AsthmaAI predictive analytics system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 180% increase in medication adherence compared to traditional reporting methods
+6 more records
Product overview1 text field

FindAir provides a comprehensive ecosystem of smart respiratory devices and software for asthma and COPD management. The portfolio consists of three core device families: (1) FindAir ONE add-on sensors that attach to existing inhalers (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) for automatic usage tracking; (2) Smarthaler Trainer for personal and professional use providing AI-powered inhalation technique analysis and training; and (3) Smarthaler Drug Delivery for pharmaceutical partners as integrated or modular connected inhaler technology. These devices connect through a software ecosystem comprising mobile apps (FindAir Asthma Diary, Research App, Smarthaler App) and web platforms (Doctor's Web Platform, Research Platform) that enable real-time patient monitoring, clinical decision support, and research data collection. The FindAir API and SDK enable third-party integration, while AsthmaAI provides AI-powered exacerbation predictions.

Product and service3 records
1FindAir ONE Smart Inhaler Add-ons
CategorySmart Inhaler Hardware
Description

A family of inhaler add-on sensors that attach to existing inhalers (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) to enable remote monitoring of medication intake, automatically logging every usage with timestamp, date, location, and adherence data for asthma and COPD patients and their care teams.

2Smarthaler Trainer Home
CategoryMedical Training Device
Description

A consumer-facing device for independent inhalation technique training at home, featuring an interactive learning system with AI-powered real-time flow analysis to help patients measure, correct, and educate about proper inhalation technique.

3Smarthaler Trainer Station
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Aptar logo appears in trusted-by section, indicating collaboration in connected drug delivery solutions. Aptar is a leading global provider of drug delivery systems.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

AstraZeneca logo appears in trusted-by section, indicating collaboration in respiratory care and connected inhaler solutions for asthma and COPD treatment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Digital health platform focused on remote patient monitoring across multiple conditions, including respiratory. Comparable as a SaaS RPM partner that could integrate with FindAir sensors via the SDK/API, but also a potential adjacent competitor for RPM contracts.

TypeBroad incumbent
Description

Global pharma with leading respiratory franchises (Symbicort, Breztri, Trixeo, Fasenra) and an active connected-device strategy. AstraZeneca is both a FindAir customer/partner and a potential competitor as it expands its own digital inhaler capabilities.

TypeBroad incumbent
Description

Parent company of Propeller Health and a major player in connected respiratory/sleep health. Provides the distribution scale, capital, and clinical evidence engine behind Propeller, the most direct competitive threat to FindAir.

TypeDirect peer
Description

The market-leading smart inhaler attachment company, now owned by ResMed, offering Bluetooth sensors and a companion app for medication adherence in asthma and COPD. Most directly comparable to FindAir's FindAir ONE add-on business, with broader commercial scale and deeper pharma partnerships.

TypeDirect peer
Description

US-based connected respiratory health company offering Bluetooth spirometers and smart inhaler sensors with a patient and clinician platform. Comparable in combining hardware sensors with software analytics for asthma and COPD management.

TypeOthers
Description

Global leader in drug delivery devices and dispensing systems for respiratory, injectable, and eye care. Listed as a FindAir trusted partner and a logical OEM collaborator for embedding Smarthaler technology into actuators, while also being a potential competitor through internal connected-device programs.

TypeBroad incumbent
Description

Major respiratory pharma (Trelegy Ellipta, Advair Diskus, Ventolin) actively investing in sensor-enabled Ellipta inhalers. A key OEM partner candidate for FindAir Smarthaler Drug Delivery and a competitor to the add-on business if Ellipta goes fully connected.

TypeDirect peer
Description

Listed (ASX/OTC) connected respiratory health company selling Hailie smart inhaler sensors for multiple inhaler formats (similar to FindAir ONE) plus a clinician portal. Direct competitor in the connected-inhaler add-on category with an FDA-cleared footprint and US commercialization history.

TypeBroad incumbent
Description

Respiratory-focused pharma (Fostair, Trimbow, Nexthaler) with growing digital health initiatives. FindAir explicitly offers a Nexthaler add-on, making Chiesi both a near-term distribution target and a long-term OEM partner candidate.

TypeBroad incumbent
Description

Pharma major with the Digihaler line of FDA-approved digital inhalers (ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler) featuring built-in sensors and companion apps. Competes with FindAir at the integrated-inhaler level and represents both a potential OEM partner and a threat to the add-on model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FindAir

Smart Inhaler Technology and Respiratory Care Devicesfindair.eu

FindAir is a Kraków-based med-tech company developing smart inhaler sensors, AI-powered inhalation training devices, and connected drug delivery technology for asthma and COPD patients, serving healthcare providers, pharmaceutical companies, clinical researchers, and medical device distributors across Europe and the US.

What FindAir does

FindAir (FindAir Sp. z o.o.) is a Kraków, Poland-based med-tech company founded in 2016 that develops smart inhaler technology and software for asthma and COPD management. Its product portfolio comprises three device families: FindAir ONE add-on sensors compatible with seven inhaler types (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler); Smarthaler Trainer (Home and Station) devices for AI-powered inhalation technique training; and Smarthaler Drug Delivery for pharmaceutical OEM and modular integration. The software stack includes mobile apps (FindAir Asthma Diary, FindAir Research App, FindAir Smarthaler App), web platforms (Doctor's Platform, Research Platform), an API and SDK for third-party integration, and AsthmaAI, a branded AI module for asthma and COPD exacerbation prediction. The company operates under ISO 13485, CE, FCC, and GDPR certifications.

FindAir generates revenue through five streams: hardware sales of FindAir ONE add-ons and Smarthaler devices via its own e-commerce store; subscription/recurring revenue from software platforms and apps; licensing and OEM/white-label partnerships with pharmaceutical companies for custom smart inhaler development; SDK and API integration services for healthcare platforms, EHRs, and research systems; and channel sales through medical device distributors. Pricing is quote-based with multi-year contracts and no public price list. Go-to-market is sales-led, combining direct enterprise outreach, industry events (TechCrunch Disrupt, Arab Health), content marketing, and distributor partnerships. Customer segments include remote patient monitoring services, pharmaceutical and drug delivery companies, health clinics and medical institutions, research and clinical trial sponsors, and medical device distributors, with named relationships including AstraZeneca, Aptar, University Health Network, Radboud UMC, UF Health, Asthma UK, University of Leicester, and RespoGene. The company operates from Poland with commercial activity across Germany, France, Portugal, and a stated US expansion initiative backed by a $1.9M seed round closed in June 2023.

FindAir firmographics

Firmographics
Name
FindAir
Legal name
Findair Sp. z o. o.
Website
https://findair.eu
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
FindAir is a Kraków-based med-tech company developing smart inhaler sensors, AI-powered inhalation training devices, and connected drug delivery technology for asthma and COPD patients, serving healthcare providers, pharmaceutical companies, clinical researchers, and medical device distributors across Europe and the US.
Ownership category
akta.pro rank

FindAir industry classification

Industry
Product category
Smart Inhaler Technology and Respiratory Care Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAIAM
Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Smart inhaler technology
  • Respiratory care devices
  • Medication adherence monitoring
  • Connected drug delivery
  • Asthma COPD management

Where FindAir is headquartered

Location

Headquarters

HQ city
Cracow
HQ country
Poland
HQ region
Europe

Offices1 record

Markets served

FindAir business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Smart Inhaler Hardware Sales: Sale of FindAir ONE add-on sensors that attach to existing inhalers for medication monitoring. Devices are sold directly through the company store and via distributors.
  2. Smarthaler Device Sales: Sale of Smarthaler Trainer devices (Home and Station versions) for inhalation technique training, both for personal/home use and professional clinical settings.
  3. Software Platform & Apps: Mobile apps (FindAir Asthma Diary, FindAir Research App, FindAir Smarthaler App) and web platforms (Doctor's Web Platform, Research Web Platform) with associated data monitoring and analytics capabilities.
  4. Pharma OEM/White-label Partnerships: Custom smart inhaler development partnerships with pharmaceutical companies to integrate Smarthaler technology into their drug delivery devices, including complete design history files and regulatory support.
  5. SDK & API Integration Services: Developer integration services enabling healthcare platforms, EHRs, and research systems to connect with FindAir devices through APIs and SDKs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for all products

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

FindAir product offering

Product offering

Core offering

FindAir designs and manufactures smart inhaler add-on sensors (FindAir ONE) that attach to existing inhaler types (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) to automatically log medication usage. The company also produces the Smarthaler Trainer (Home and Station variants) for AI-powered inhalation technique training, and offers Smarthaler Drug Delivery technology for pharmaceutical partners to integrate connected monitoring into their inhaler devices. These hardware products are complemented by mobile apps, web platforms for clinicians and researchers, and the AsthmaAI predictive analytics system.

Product overview

FindAir provides a comprehensive ecosystem of smart respiratory devices and software for asthma and COPD management. The portfolio consists of three core device families: (1) FindAir ONE add-on sensors that attach to existing inhalers (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) for automatic usage tracking; (2) Smarthaler Trainer for personal and professional use providing AI-powered inhalation technique analysis and training; and (3) Smarthaler Drug Delivery for pharmaceutical partners as integrated or modular connected inhaler technology. These devices connect through a software ecosystem comprising mobile apps (FindAir Asthma Diary, Research App, Smarthaler App) and web platforms (Doctor's Web Platform, Research Platform) that enable real-time patient monitoring, clinical decision support, and research data collection. The FindAir API and SDK enable third-party integration, while AsthmaAI provides AI-powered exacerbation predictions.

Differentiator

Problem solved

Functional benefit

Brands

  • FindAir ONE: Smart inhaler add-on sensors that attach to existing inhalers for medication intake monitoring and adherence tracking
  • Smarthaler
  • AsthmaAI
  • FindAir Asthma Diary
  • Smarthaler Trainer
  • FindAir Research Platform

Products and services

  • FindAir ONE Smart Inhaler Add-ons A family of inhaler add-on sensors that attach to existing inhalers (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) to enable remote monitoring of medication intake, automatically logging every usage with timestamp, date, location, and adherence data for asthma and COPD patients and their care teams.
  • Smarthaler Trainer Home A consumer-facing device for independent inhalation technique training at home, featuring an interactive learning system with AI-powered real-time flow analysis to help patients measure, correct, and educate about proper inhalation technique.
  • Smarthaler Trainer Station

Quantifiable outcome

  • 180% increase in medication adherence compared to traditional reporting methods
  • +6 more outcomes

Companies that use FindAir

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles5 records

FindAir technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature6 records

FindAir partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • AptarcoreStrategic or Co-development PartnerAptar logo appears in trusted-by section, indicating collaboration in connected drug delivery solutions. Aptar is a leading global provider of drug delivery systems.
  • AstraZenecacoreStrategic or Co-development PartnerAstraZeneca logo appears in trusted-by section, indicating collaboration in respiratory care and connected inhaler solutions for asthma and COPD treatment.

Scale indicators5 records

Recent moves6 records

Expansion highlights8 records

FindAir competitors and assessment

Company assessment

Emerging players

  • Huma Therapeutics: Digital health platform focused on remote patient monitoring across multiple conditions, including respiratory. Comparable as a SaaS RPM partner that could integrate with FindAir sensors via the SDK/API, but also a potential adjacent competitor for RPM contracts.

Broad incumbents

  • AstraZeneca: Global pharma with leading respiratory franchises (Symbicort, Breztri, Trixeo, Fasenra) and an active connected-device strategy. AstraZeneca is both a FindAir customer/partner and a potential competitor as it expands its own digital inhaler capabilities.
  • ResMed: Parent company of Propeller Health and a major player in connected respiratory/sleep health. Provides the distribution scale, capital, and clinical evidence engine behind Propeller, the most direct competitive threat to FindAir.
  • GSK (GlaxoSmithKline): Major respiratory pharma (Trelegy Ellipta, Advair Diskus, Ventolin) actively investing in sensor-enabled Ellipta inhalers. A key OEM partner candidate for FindAir Smarthaler Drug Delivery and a competitor to the add-on business if Ellipta goes fully connected.
  • Chiesi: Respiratory-focused pharma (Fostair, Trimbow, Nexthaler) with growing digital health initiatives. FindAir explicitly offers a Nexthaler add-on, making Chiesi both a near-term distribution target and a long-term OEM partner candidate.
  • Teva Pharmaceutical Industries (Digihaler): Pharma major with the Digihaler line of FDA-approved digital inhalers (ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler) featuring built-in sensors and companion apps. Competes with FindAir at the integrated-inhaler level and represents both a potential OEM partner and a threat to the add-on model.

Direct peers

  • Propeller Health (ResMed): The market-leading smart inhaler attachment company, now owned by ResMed, offering Bluetooth sensors and a companion app for medication adherence in asthma and COPD. Most directly comparable to FindAir's FindAir ONE add-on business, with broader commercial scale and deeper pharma partnerships.
  • Cohero Health: US-based connected respiratory health company offering Bluetooth spirometers and smart inhaler sensors with a patient and clinician platform. Comparable in combining hardware sensors with software analytics for asthma and COPD management.
  • Adherium: Listed (ASX/OTC) connected respiratory health company selling Hailie smart inhaler sensors for multiple inhaler formats (similar to FindAir ONE) plus a clinician portal. Direct competitor in the connected-inhaler add-on category with an FDA-cleared footprint and US commercialization history.

Others

  • Aptar Pharma: Global leader in drug delivery devices and dispensing systems for respiratory, injectable, and eye care. Listed as a FindAir trusted partner and a logical OEM collaborator for embedding Smarthaler technology into actuators, while also being a potential competitor through internal connected-device programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

FindAir social profiles

Digital presence

FindAir compliance and trust

Trust signal

Compliance4 records

FindAir financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FindAir leadership team

Management profile

Number of profiles

Profiles3 records

FindAir funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FindAir M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FindAir

What does FindAir do?

FindAir designs and manufactures smart inhaler add-on sensors (FindAir ONE) that attach to existing inhaler types (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) to automatically log medication usage. The company also produces the Smarthaler Trainer (Home and Station variants) for AI-powered inhalation technique training, and offers Smarthaler Drug Delivery technology for pharmaceutical partners to integrate connected monitoring into their inhaler devices. These hardware products are complemented by mobile apps, web platforms for clinicians and researchers, and the AsthmaAI predictive analytics system.

Is FindAir a public or private company?

FindAir is a private company. It is classified as venture growth investor backed and is currently operating.

When was FindAir founded?

FindAir was founded in 2016. It employs 11 to 50 people.

Where is FindAir based?

FindAir is headquartered in Cracow, Poland, in the Europe region.

How does FindAir make money?

Five revenue lines are on record. Smart Inhaler Hardware Sales are the primary driver. The others are smarthaler Device Sales, software Platform & Apps, pharma OEM/White-label Partnerships and SDK & API Integration Services.

Who are FindAir's main competitors?

Huma Therapeutics is listed as an emerging player. Broad incumbents are AstraZeneca, ResMed, GSK (GlaxoSmithKline), Chiesi and Teva Pharmaceutical Industries (Digihaler). Direct peers are Propeller Health (ResMed), Cohero Health and Adherium. Aptar Pharma is listed as an others.

Does FindAir have an API?

Yes. FindAir API enables seamless connection between systems and all FindAir devices, providing quick access to accurate medication usage and inhalation data. Designed with security and compliance in mind, the API ensures reliable data transfer while offering comprehensive developer documentation. Supports integration with clinical platforms, research tools, and patient management systems.

What industry is FindAir in?

FindAir's product category is Smart Inhaler Technology and Respiratory Care Devices. Its primary akta.pro industry code is HLAHAIAM, Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps), with a secondary code of HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechCrunchFindAir is a smart inhalerFindAir is a startup that digitizes asthma therapy through the use of smart inhaler technology, as highlighted in coverage from TechCrunch Disrupt. The company focuses on integrating digital capabilities into medical devices to improve patient management. This announcement represents a niche product introduction within the health-tech sector.Spider's WebZnamy zwycięzcę UPC Digital Imagination ChallengeThe UPC Digital Imagination Challenge selected six finalists, with Findair winning the top prize. The winner's Findair inhalator and overlay monitor asthma attacks, while the runner-ups were AudioMovie and Nexbio. The challenge aims to encourage private investment in innovative startups.AntywebFindAir najlepszym startupem! Podsumowanie infoShare 2017FindAir won the InfoShare 2017 competition, taking first place and second place in the overall contest. The Gdańsk city prize of 20,000 Euro, plus a previous win, totals nearly 40,000 Euro, with a path to a million-euro investment. The startup's asthma app and sensor recorded 200 startups from over 20 countries.INNPoland.plWłaśnie poznaliśmy polski start-up roku. Po błyskotliwym triumfie do FindAir ustawia się kolejka inwestorówFindAir founders won €20,000 from Gdańsk and €17,000 from Digital Healthcare Hackathon at InfoShare. The startup, founded last October, has a long line of investors and plans to launch its inhalator hardware this year. The app already exists on Google Play, but manual data entry is required.PolskieRadio.plKrakowscy naukowcy wynaleźli inteligentny inhalator dla astmatykówDr. Tomasz Nowakowski warned that recurrent headaches should not be ignored, as they can signal serious conditions like stroke or aneurysm rupture. He cited WHO data showing 47% of people experience recurring headaches, and noted that in the EU, migraine-related absenteeism totals 190 million workdays annually, with headache treatment costs reaching €155 billion.PapKrakowscy naukowcy wynaleźli inteligentny inhalator dla astmatykówKrakow scientists developed an intelligent inhalator for asthmatics that connects to a mobile app to predict attacks. Testing begins in January with 40 patients, with sales planned for spring. The project received €15,000 from a Berlin incubator.